
Leukopast 3 Cattle
From R 466.31
- 500ml
- 100ml
- CapeCross
Combined formalinised, aluminium hydroxide gel adsorbed monovalent leukotoxin culture supernatant of Mannheimia (Pasteurella) haemolytica type A 1 with inactivated infectious bovine rhinotracheitis and parainfluenza type 3 virus for the control of respiratory infections in cattle
RECOMMENDATIONS FOR USE:
In South Africa Mannheimia (Pasteurella) haemolytica and respiratory virus infections occur primarily in feedlot cattle kept under intensive conditions as well as in young animals under extensive conditions on farms.
The pneumonic form of pasteurellosis in feedlot cattle is preceded by infections with infectious bovine rhinotracheitis and parainfluenza type 3 virus and stress conditions. Cattle should, therefore, be immunised against infectious bovine rhinotracheitis, parainfluenza type 3 and pasteurellosis before they are introduced into feedlots.
WARNINGS:
Do not slaughter animals for human consumption within 7 days of vaccination. Vaccinate healthy animals only. Keep out of reach of children, uninformed persons and animals. Although this product has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.
DIRECTIONS FOR USE:
Use only as directed.
Sterilise syringes and needles by boiling in water for at least 15 minutes. Do not use disinfectants or methylated spirits for sterilising either syringes or needles. Use a separate needle for each animal. Shake the bottle well before use. Avoid exposure to high temperatures and direct sunlight during inoculation. Depending on circumstances,
animals may be immunised at any age from two weeks. Animals which are inoculated for the first time must be given 2 injections with an interval of 4 weeks. Thereafter a single booster injection should be given every 6 to 12 months. It is advisable to give this injection approximately a month before the anticipated occurrence of the disease.
DOSAGE: 5 ml subcutaneously irrespective of age or body mass
EFFECTS OF THE VACCINE:
The vaccine causes no reaction. Pregnant and lactating animals may be inoculated. Immunity develops approximately two weeks after inoculation and protection lasts for about 6 months but cannot be guaranteed in all animals.
At all times store the vaccine at a temperature of 4 ˚C to 8 ˚C in a refrigerator. Do not use the vaccine after the expiry date printed on the bottle.